Theravance Biopharma Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 05:30PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst

Good afternoon. Welcome, everyone. My name is Vikram Purohit. I'm one of the biotech analysts at Morgan Stanley. And before we get started with Theravance today, need to read a brief disclosure.

Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.

Okay. With that, I'd like to welcome Rick, Andrew and Brett, CEO, CFO and CMO of Theravance Biopharma to our fireside chat. Welcome.

Rick E. Winningham - Theravance Biopharma, Inc. - Chairman & CEO

Thank you.

Vikram Purohit<

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot